Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries
CONCLUSIONS: Our results indicated that two doses of varicella zoster virus-containing vaccine provided better protection than one dose against varicella and induced antibody responses that persisted 10 years post-vaccination.PMID:33858718 | DOI:10.1016/j.vaccine.2021.03.085
Source: Vaccine - Category: Allergy & Immunology Authors: Roman Prymula Michael Povey Jerzy Brzostek Hana Cabrnochova Roman Chlibek Hanna Czajka Giedra Leviniene Sorin Man Mihai Neamtu Petr Pazdiora Doina Plesca Renata Ruzkova Maria Stefkovicova Vytautas Usonis Daniela Verdanova Jacek Wysocki Giacomo Casabona Md Source Type: research
More News: Allergy & Immunology | Children | Czechia Health | Epidemiology | Eyes | Lithuania Health | Measles | Measles Vaccine | MMR (Measles,Mumps,Rubella) Vaccine | Mumps | Mumps Vaccine | Poland Health | Romania Health | Rubella | Rubella Vaccine | Slovakia Health | Vaccines | Varicella-Zoster Virus Vaccine